Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study

BACKGROUND: Several studies have suggested a survival benefit of neoadjuvant therapy (NAT) for pancreatic ductal adenocarcinoma (PDAC) in the pancreatic head. Data concerning NAT for PDAC located in pancreatic body or tail are lacking. METHODS: Post hoc analysis of an international multicenter retro...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ann Surg Oncol
Autori principali: Lof, Sanne, Korrel, Maarten, van Hilst, Jony, Alseidi, Adnan, Balzano, Gianpaolo, Boggi, Ugo, Butturini, Giovanni, Casadei, Riccardo, Dokmak, Safi, Edwin, Bjørn, Falconi, Massimo, Keck, Tobias, Malleo, Giuseppe, de Pastena, Matteo, Tomazic, Ales, Wilmink, Hanneke, Zerbi, Alessandro, Besselink, Marc G., Abu Hilal, Mohammed
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer International Publishing 2019
Soggetti:
Pancreatic Tumors
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7210228/
https://ncbi.nlm.nih.gov/pubmed/31848815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-019-08137-6
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi